Higher Plasma Viremia in the Febrile Phase Is Associated With Adverse Dengue Outcomes Irrespective of Infecting Serotype or Host Immune Status: An Analysis of 5642 Vietnamese Cases
Open Access
- 15 June 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 72 (12), E1074-E1083
- https://doi.org/10.1093/cid/ciaa1840
Abstract
Background. One of the generally accepted constructs of dengue pathogenesis is that clinical disease severity is at least partially dependent upon plasma viremia, yet data on plasma viremia in primary versus secondary infections and in relation to clinically relevant endpoints remain limited and contradictory. Methods. Using a large database comprising detailed clinical and laboratory characterization of Vietnamese participants enrolled in a series of research studies executed over a 15-year period, we explored relationships between plasma viremia measured by reverse transcription-polymerase chain reaction and 3 clinically relevant endpoints-severe dengue, plasma leakage, and hospitalization-in the dengue-confirmed cases. All 4 dengue serotypes and both primary and secondary infections were well represented. In our logistic regression models we allowed for a nonlinear effect of viremia and for associations between viremia and outcome to differ by age, serotype, host immune status, and illness day at study enrollment. Results. Among 5642 dengue-confirmed cases we identified 259 (4.6%) severe dengue cases, 701 (12.4%) patients with plasma leakage, and 1441 of 4008 (40.0%) patients recruited in outpatient settings who were subsequently hospitalized. From the early febrile phase onwards, higher viremia increased the risk of developing all 3 endpoints, but effect sizes were modest (ORs ranging from 1.12-1.27 per 1-log increase) compared with the effects of a secondary immune response (ORs, 1.67-7.76). The associations were consistent across age, serotype, and immune status groups, and in the various sensitivity and subgroup analyses we undertook. Conclusions. Higher plasma viremia is associated with increased dengue severity, regardless of serotype or immune status.Funding Information
- Wellcome Trust (084368/Z/07/Z)
- Oxford University Clinical Research Unit (077078/Z/05/Z, 077078/Z/05/A, 089276/B/09/Z)
- European Union (FP7-281803)
This publication has 29 references indexed in Scilit:
- Mapping global variation in dengue transmission intensityScience Translational Medicine, 2020
- DengueThe Lancet, 2019
- The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and PathogenesisAnnual Review of Virology, 2018
- Antibody-dependent enhancement of severe dengue disease in humansScience, 2017
- Pathogenesis of vascular leak in dengue virus infectionImmunology, 2017
- Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to HyperpermeabilityPLoS Pathogens, 2016
- Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infectionArchiv für die gesamte Virusforschung, 2013
- Timing of CD8+ T Cell Responses in Relation to Commencement of Capillary Leakage in Children with DengueThe Journal of Immunology, 2010
- Dengue in Vietnamese Infants—Results of Infection‐Enhancement Assays Correlate with Age‐Related Disease Epidemiology, and Cellular Immune Responses Correlate with Disease SeverityThe Journal of Infectious Diseases, 2008
- Antibody, Macrophages, Dengue Virus Infection, Shock, and Hemorrhage: A Pathogenetic CascadeClinical Infectious Diseases, 1989